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Abstract
Background: Astroglial cells are activated following injury and up-regulate the expression of the intermediate filament
proteins glial fibrillary acidic protein (GFAP) and vimentin. Adult mice lacking the intermediate filament proteins GFAP and
vimentin (GFAP
2/2Vim
2/2) show attenuated reactive gliosis, reduced glial scar formation and improved regeneration of
neuronal synapses after neurotrauma. GFAP
2/2Vim
2/2 mice exhibit larger brain infarcts after middle cerebral artery
occlusion suggesting protective role of reactive gliosis after adult focal brain ischemia. However, the role of astrocyte
activation and reactive gliosis in the injured developing brain is unknown.
Methodology/Principal Findings: We subjected GFAP
2/2Vim
2/2 and wild-type mice to unilateral hypoxia-ischemia (HI) at
postnatal day 9 (P9). Bromodeoxyuridine (BrdU; 25 mg/kg) was injected intraperitoneally twice daily from P9 to P12. On P12
and P31, the animals were perfused intracardially. Immunohistochemistry with MAP-2, BrdU, NeuN, and S100 antibodies was
performed on coronal sections. We found no difference in the hemisphere or infarct volume between GFAP
2/2Vim
2/2 and
wild-type mice at P12 and P31, i.e. 3 and 22 days after HI. At P31, the number of NeuN
+ neurons in the ischemic and
contralateral hemisphere was comparable between GFAP
2/2Vim
2/2 and wild-type mice. In wild-type mice, the number of
S100
+ astrocytes was lower in the ipsilateral compared to contralateral hemisphere (65.0650.1 vs. 85.6634.0, p,0.05). In
the GFAP
2/2Vim
2/2 mice, the number of S100
+ astrocytes did not differ between the ischemic and contralateral
hemisphere at P31. At P31, GFAP
2/2Vim
2/2 mice showed an increase in NeuN
+BrdU
+ (surviving newly born) neurons in the
ischemic cortex compared to wild-type mice (6.767.7; n=29 versus 2.963.6; n=28, respectively, p,0.05), but a comparable
number of S100
+BrdU
+ (surviving newly born) astrocytes.
Conclusions/Significance: Our results suggest that attenuation of reactive gliosis in the developing brain does not affect
the hemisphere or infarct volume after HI, but increases the number of surviving newborn neurons.
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Introduction
The central nervous system (CNS) contains abundance of
astroglial cells which induce formation of neuronal synapses and
support neurons structurally and metabolically [1]. Astrocytes
become activated by many pathological conditions such as
neurotrauma, stroke, perinatal asphyxia or neurodegenerative
diseases. One of the hallmarks of astrocyte activation and the
resulting reactive gliosis is the upregulation of the intermediate
filament (IF) system (known also as nanofilament system)
composed of glial fibrillary acidic protein (GFAP), vimentin,
nestin and synemin [2,3]. The function of reactive astrocytes in
neuroprotection or recovery of the CNS from an injury is not
fully understood. Neuroprotection by reactive astrocytes
through up-regulation of glutathione was demonstrated follow-
ing oxidative stress [4,5]. On the other hand, reactive gliosis
may inhibit neuroregeneration and outgrowth of axons and
dendrites [6].
PLoS ONE | www.plosone.org 1 April 2010 | Volume 5 | Issue 4 | e10397Mice lacking the IF proteins GFAP and vimentin
(GFAP
2/2Vim
2/2) showed that up-regulation of astrocyte IF is a
key step in activation of astrocytes and that reactive gliosis is
important for the wound healing process [3,7,8,9]. Reactive
astrocytes in GFAP
2/2Vim
2/2 mice are unable to form any
cytoplasmic IFs since neither nestin nor synemin can self-polymerize
or co-polymerize in the absence of both GFAP, and vimentin [2,10].
After neurotrauma, GFAP
2/2Vim
2/2 mice show attenuated reactive
gliosis with reduced hypertrophy of astrocyte processes and increased
synaptic loss in the acute stage of the injury [8,11], however, the
regeneration of neuronal synapses at a later stage is improved [11].
Focal brain ischemia induced by middle cerebral artery transection
ledtoincreasedinfarctioninGFAP
2/2Vim
2/2mice,whichsuggested
protective role of reactive astrocytes in adult brain ischemia.
Here we subjected GFAP
2/2Vim
2/2 mice to unilateral hypoxia-
ischemia at postnatal day 9 [12,13,14] to address the importance of
astrocyte IFs and reactive gliosis in perinatal asphyxia. We found
no difference in the hemisphere or infarct volume between
GFAP
2/2Vim
2/2andwild-typemice.However,theGFAP
2/2Vim
2/2
mice showed a larger number of surviving newly born neurons. In
contrast to wild-type mice, we did not find a loss of S100
+ astrocytes in
the ischemic hemisphere of GFAP
2/2Vim
2/2 mice.
Results
Hypoxia-Ischemia Increases GFAP mRNA Expression
To assess the effect of hypoxia-ischemia (HI) on GFAP
expression in wild-type mice, we measured relative GFAP mRNA
expression immediately after, 6 hours, 24 hours, 3 days, 7 days
and 21 days after HI. Twenty four hours after HI, GFAP mRNA
expression in the cortex was substantially increased (2.760.8,
n=3) compared to 6 hours (0.960.2, n=4, p,0.01) or 3 days
after HI (1.060.2, n=4, p,0.01; Fig. 1). These data show that,
astrocytes respond to HI by up-regulation of GFAP, within the
first 24 hours after ischemic insult.
The Absence of GFAP and Vimentin Does Not Affect
Brain Growth or Infarct Volume after Hypoxia-Ischemia
Next, we assessed the hemisphere and infarct volume in
GFAP
2/2Vim
2/2 and wild-type mice at 3 and 22 days after
ischemia. Three days after HI (P12), there was no difference in the
volume of the ipsilateral hemisphere between GFAP
2/2Vim
2/2
and wild-type mice (9.463.7 mm
3,n = 2 3vs. 9.764.1 mm
3,
n=19). The volume of the contralateral hemisphere was
comparable in GFAP
2/2Vim
2/2 and wild-type mice
(13.563.1 mm
3 vs. 12.263.5 mm
3) (Fig. 2a). Further, there was
no difference in the volume of the ipsilateral hemisphere
(38.9610.3 mm
3,n = 2 6vs. 35.5611.7 mm
3, n=27) or the
contralateral hemisphere (46.068.5 mm
3 vs. 44.267.1 mm
3)
between GFAP
2/2Vim
2/2 and wild-type mice at P31, i.e. 22 days
after HI (Fig. 2a). We did not find any difference in the infarct
volume between GFAP
2/2Vim
2/2 and wild-type mice at P12
(2.761.7 mm
3,n = 2 3vs. 2.763.0 mm
3, n=19) or at P31
(2.964.1 mm
3,n = 2 6vs. 3.765.1 mm
3, n=27; Fig. 2b). Next,
we used immunohistochemistry with antibodies against neurofil-
ament proteins to visualize neuronal axons in the vicinity of the
Figure 1. GFAP mRNA expression in mice after hypoxia-
ischemia, assessed by quantitative rt-PCR. Cortex from wild-type
mice exposed to hypoxia-ischemia on P9, examined by quantitative rt-
PCR immediately after (n=6), 6 h (n=4), 24 h (n=3), 3d (n=4), 7d
(n=4), and 21d (n=4) after hypoxia-ischemia. The values represent a
fold increase compared to 0 hours after HI. Data are mean 6 SD
(** p,0.01).
doi:10.1371/journal.pone.0010397.g001
Figure 2. Hemisphere and infarct volume in GFAP
2/2Vim
2/2 and
wild-type mice after hypoxia-ischemia. Volume measurements
in MAP-2 stained sections from GFAP
2/2Vim
2/2 (GV) (n=23) and
wild-type (WT) (n=19) mice at P12 and P31, i.e. 3 and 22 days after
hypoxia-ischemia. (A) Ipsi- and contralateral hemisphere volume in
GFAP
2/2Vim
2/2 and wild-type mice. (B) Infarction volume in
GFAP
2/2Vim
2/2 and wild-type mice. Data are mean 6 SD.
doi:10.1371/journal.pone.0010397.g002
HI in GFAP
2/2Vim
2/2 Mice
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hemisphere. We did not find any difference in the apperence of
neuronal axons between the GFAP
2/2Vim
2/2 and wild-type mice
(Fig. 3).
The GFAP
2/2Vim
2/2 Mice Have Higher Cortical
Neurogenesis after Hypoxia-Ischemia
To assess the effect of HI on neuronal survival outside the
infarct, we counted the NeuN
+ neurons in the subventricular zone
region, striatum and cortex. As a measure of HI-induced
neurogenesis, we counted NeuN
+BrdU
+ cells (surviving newly
born neurons) in the same brain regions. We did not find any
difference in the number of NeuN
+ neurons in the ipsilateral
(539.66215.7, n=29 vs. 423.66251.9 per optical field, n=28) or
contralateral (646.0690.5 vs. 660.2687.9 per optical field)
hemisphere between GFAP
2/2Vim
2/2 and wild-type mice at
P31 (Fig. 4a). In wild-type mice, the number of NeuN
+ neurons in
the contralateral hemisphere compared to the ipsilateral hemi-
sphere was higher in the subventricular zone (88.3616.3 vs.
70.4631.0 per optical field, p,0.01), striatum (358.8650.7 vs.
241.46146.0 per optical field, p,0.001) and cortex (213.1637.6
vs. 111.8699.9 per optical field, p,0.001). In GFAP
2/2Vim
2/2
mice, a higher number of NeuN
+ neurons in contralateral
compared to the ipsilateral hemisphere was observed in cortex
(197.7628.0 vs. 149.5682.9 per optical field, p,0.01; Fig. 4a) but
not in the other regions. The GFAP
2/2Vim
2/2 mice had an
increased number of NeuN
+BrdU
+ cells in ipsilateral cortex
compared to wild-type mice (6.767.7, n=29 vs. 2.963.6 per
optical field, n=28, p,0.05). Compared to the ipsilateral
hemisphere, the wild-type mice had a higher number of
Figure 3. Visualization of neuronal axons in the infact area and in the contralateral hemisphere. Neuronal axons were visualized with
antibodies against neurofilament proteins on sections from wild-type (A-D) and GFAP
2/2Vim
2/2 (E-H) mice at P12, i.e. 3 days after hypoxia-ischemia.
The frames indicate respective fields for higher magnification. Scale bar for A, C, E, G=500 mm; for B, D, F, H=50 mm.
doi:10.1371/journal.pone.0010397.g003
HI in GFAP
2/2Vim
2/2 Mice
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+BrdU
+ neurons in the contralateral subventricular
zone (4.964.7 vs. 6.364.4 per optical field, p,0.05) and
cortex (2.963.6 vs. 5.664.4 per optical field, p,0.05; Fig. 4b).
GFAP
2/2Vim
2/2 and wild-type mice not exposed to HI had a
very small number of NeuN
+BrdU
+ neurons in the subventricular
zone (0.560.4, n=12 vs. 0.560.6 per optical field, n=6), striatum
(0.660.6 vs 0.160.2 per optical field) and cortex (0 vs. 0.160.2 per
optical field).
Hypoxia-Ischemia Leads to the Loss of Astrocytes in Wild-
Type but Not GFAP
2/2Vim
2/2 Mice
Next, we assessed the effect of HI on astrocyte numbers and
counted S100
+ astrocytes in the subventricular zone region,
striatum and cortex. As a measure of HI-induced astrogenesis, we
counted S100
+BrdU
+ cells (surviving newly born astrocytes) in the
same brain regions. In GFAP
2/2Vim
2/2 mice, the number of
S100
+ astrocytes did not differ between the ischemic and
contralateral hemisphere at P31 (Fig. 5a). In wild-type mice, the
number of S100
+ astrocytes was lower in the ipsilateral compared
to contralateral hemisphere (65.0650.1 vs. 85.6634.0 per optical
field, p,0.05), both in subventricular zone (7.565.4 vs. 9.764.7
per optical field, p,0.05) and in the cortex (18.0617.1 vs.
27.869.5 per optical field, p,0.01; Fig. 5a). The GFAP
2/2Vim
2/2
and wild-type mice did not differ in the histomorphology of S100
+
astrocytes as assessed by the length of the longest cellular
process of astrocytes in the cortex around the infarct area
at P31 (16.061.5 mm, n=6 vs. 16.560.6 mm, n=6). The
GFAP
2/2Vim
2/2 and wild-type mice did not differ in number of
S100
+BrdU
+ cells (surviving newly born astrocytes) (Fig. 5b).
Discussion
Astrocytes respond to hypoxia-ischemia (HI) by morphological
and functional changes as early as 8 hours after the insult and have
been implicated to play a role in the pathophysiological events that
lead to the brain damage after HI [15,16]. To investigate the role
of reactive astrocytes in response to hypoxic-ischemic brain injury
in the immature brain, we used mice in which astrocyte activation
is attenuated due to the lack of intermediate filament proteins
GFAP and vimentin [3,8] and subjected them to neonatal HI. We
found that attenuation of reactive gliosis does not have any effect
on the infarct volume or the volume of the injured hemisphere,
neither at an early (3 days) nor a late (22 days) time point. Thus, in
contrast to the adult brain, where reactive astrocytes play a critical
role in protecting the ischemic penumbra [17], in the immature
brain reactive gliosis does not seem to play a major neuroprotec-
tive role. The immature and adult brain differ in their responses to
ischemic injury, such as leukocyte transmigration [18], activation
of microglia [19], cytokine and chemokine interplay [20],
excitotoxicity [21] and mitochondria-regulated apoptotic mecha-
nisms [22,23]. The present results support the notion that also the
role of astrocytes in the pathogenesis of ischemic brain injury
depends on the developmental age which has to be taken into
consideration in designing future neuroprotective strategies.
We have also found that both the wild-type and the
GFAP
2/2Vim
2/2 mice responded to HI by increased production
of new neurons. Interestingly, the wild-type mice showed a lower
number of surviving newly born neurons in the ischemic
subventricular zone and the cortex compared to the contralateral
hemisphere, whereas in the GFAP
2/2Vim
2/2 mice the neurogenic
response to ischemia was the same in the two hemispheres. Since
neuronal cell loss in the ischemic hemisphere was comparable
between the wild-type and GFAP
2/2Vim
2/2 mice, it is conceiv-
able that the absence of reactive gliosis results in a niche that is
more permissive to neurogenesis and the survival of newly formed
neurons after ischemia. Indeed, we have earlier shown that
survival and integration of neuronal grafts is increased in the CNS
Figure 4. Quantification of NeuN
+ and NeuN
+BrdU
+ cells at 22
days after hypoxia-ischemia. (A) Number of NeuN
+ cells per optical
field in the ipsi- and contralateral subventricular zone, striatum and
cortex, in GFAP
2/2Vim
2/2 (GV) (n=29) and wild-type (WT) (n=28) mice
at P31, i.e. 22 days after hypoxia-ischemia. (B) Number of NeuN
+BrdU
+
cells per optical field in ipsi- and contralateral subventricular zone,
striatum and cortex, in GFAP
2/2Vim
2/2 (n=29) and wild-type (n=28)
mice at P31, i.e. 22 days after hypoxia-ischemia. The numbers represent
cells counted on 8 mm thick stacks of confocal images within the
450 mm6300 mm optical fields in the respective brain regions. (C)
Orthogonal sections showing NeuN
+BrdU
+ cells. Data are mean 6 SD.
(* p,0.05, ** p,0.01, *** p,0.001). Scale bar=15 mm.
doi:10.1371/journal.pone.0010397.g004
HI in GFAP
2/2Vim
2/2 Mice
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2/2Vim
2/2 mice [24,25] and that basal hippocampal
neurogenesis and cell proliferation is increased in aged
GFAP
2/2Vim
2/2 mice [26].
Remarkably, we found that HI led to the loss of S100
+
astrocytes in the ischemic hemisphere of wild-type but not
GFAP
2/2Vim
2/2 mice. The GFAP
2/2Vim
2/2 and wild-type mice
did not differ in the number of surviving newly formed astrocytes.
These findings suggest that the astrocytes lacking GFAP and
vimentin might be less vulnerable to ischemic stress. Indeed, the
dynamics of the response of GFAP
2/2Vim
2/2 astrocytes to
hypotonic stress, a component of HI, might be altered. It was
previously shown that GFAP
2/2Vim
2/2 astrocytes in vitro reacted
to hypotonic stress by releasing less taurine than wild type
astrocytes [27] and that GFAP
2/2Vim
2/2 astrocytes exhibited
more prolonged changes in extracellular space diffusion param-
eters than wild-type astrocytes during cell swelling evoked by
hypotonic stress or high concentration of potassium [28].
In summary, our data suggest that in contrast to its protective
role in adult focal brain ischemia, reactive gliosis does not seem to
play a major role in the protection of brain tissue against HI injury
in the immature brain. Thus, the role of reactive astrocytes in the
pathogenesis of ischemic brain injury might be profoundly affected
by age at the time of insult.
Materials and Methods
Ethics Statement
The animal experiments were approved by the local Animal
Ethics Committee at the University of Gothenburg (Ethical
approval 29-2006).
Animals and Surgery
The GFAP
2/2Vim
2/2 and wild-type mice were on a mixed
C57BL6/129SV/129Ola genetic background [8,10,29]. Neonatal
HI was induced on P9, as previously described with modifications
for mice [12,13,14]. The mice were anesthetized with isoflurane
(Baxter Medical), 3.5% for the induction and 1.5% to continue, in
50% oxygen and 50% nitrous oxide. The left common carotid
artery was dissected and permanently ligated with a prolene suture
(6.0). The incision was closed and infiltrated with lidokain
(XylocainH, Astra Zeneca). The mice were injected intraperitone-
ally (i.p.) with bromodeoxyuridine (BrdU) (Sigma-Aldrich)
(25 mg/kg body weight), dissolved in 0.9% NaCl saline twice
daily from P9 to P12. The mice were then returned to their
mothers for 1 hour and then placed in a chamber with humidified
air at 36uC for 10 minutes and exposed to humidified 10% oxygen
in nitrogen, for 30 minutes at 36uC and kept in humidified air at
36uC for 10 additional minutes before returning to their mothers.
Immunohistochemistry
The mice were deeply anesthetized with thiopenthal (50 mg/
ml) (PentothalH Sodium, Hospira) i.p. on P12 or P31. The mice
were perfusion fixed intracardially with 0.9% NaCl followed by
5% paraformaldehyde (Histofix, Histolab). The brains were
removed and post-fixed in 5% paraformaldehyde for 24 hours at
4uC, placed in 70% ethanol for 24 hours at room temperature
(RT), dehydrated and embedded in paraffin. The brains were cut
in 8 mm coronal sections using a water microtome (Rotary
Microm HM 355S, Microm International). For immunohisto-
chemical staining, sections were deparaffinised in xylene and
alcohol and boiled in 0.01 M citric acid buffer (pH 6.0) for 10
minutes, incubated in phosphate buffered saline (PBS) with 3%
H2O2 for 10 minutes, in 2 M HCl for 1 hour and then 30 minutes
in PBS with 0.2% Triton X-100 and 3% BSA.
For brain infarction area evaluation, the primary monoclonal
mouse anti-microtubule-associated protein-2 (MAP-2) antibody
(Sigma-Aldrich) 1:2000 and anti-pan-neurofilament protein (SMI
312) antibody (Covance) 1:2000 were used with the secondary
horse-anti-mouse, BA-2001 antibody (Vector Laboratories)
Figure 5. Quantification of S100
+ and S100
+BrdU
+ cells at 22
days after hypoxia-ischemia. (A) Number of S100
+ cells per optical
field in ipsi- and contralateral subventricular zone, striatum and cortex,
in GFAP
2/2Vim
2/2 (GV) (n=29) and wild-type (WT) (n=28) mice at P31,
i.e. 22 days after hypoxia-ischemia. (B) Number of S100
+BrdU
+ cells per
optical field in ipsi and contralateral subventricular zone, striatum and
cortex, in GFAP
2/2Vim
2/2 (n=29) and wild-type (n=28) mice at P31, i.e.
22 days after hypoxia-ischemia. The numbers represent cells counted
on 8 mm thick stacks of confocal images within the 450 mm6300 mm
optical fields in the respective brain regions. (C) Orthogonal sections
showing S100
+BrdU
+ cells. Data are mean 6 SD. (* p,0.05, ** p,0.01).
Scale bar =15 mm.
doi:10.1371/journal.pone.0010397.g005
HI in GFAP
2/2Vim
2/2 Mice
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ABC-Elite (Vector Laboratories) for 1 hour and visualized with
3,3-diaminobenzidine (DAB; 0.5 mg/ml) and nickel sulphate
(15 mg/ml).
The following antibodies were used for fluorescent staining at
the following dilutions: primary monoclonal mouse anti-BrdU
antibody (Dako) 1:100 with the secondary goat anti-mouse Alexa
Fluor 594 antibody (Invitrogen) 1:500, primary monoclonal mouse
anti-NeuN biotin conjugated antibody (Chemicon) 1:100 with the
secondary Streptavidin Alexa Fluor 488 antibody (Invitrogen)
1:500, primary polyclonal rabbit anti-S100 antibody (Dako) 1:200
with the secondary goat anti-rabbit Alexa Fluor 488 antibody
(Invitrogen) 1:500. The primary antibody solution was left on the
sections over night, in a dark room at 4uC. The sections were
washed in PBS and the secondary antibody solution was added for
1 hour at RT. Finally, the sections were washed in PBS and
mounted with Dako fluorescent mounting medium.
Brain Infarction Area Evaluation
A CCD camera (Olympus DP50) connected to a microscope
(Optiphot-2, Nikon) was used to obtain images of the MAP-2
stained brain sections for calculation of the infarct volume and
hemisphere volume. Olympus Micro Image, v4.0 software was
used to delineate MAP-2 positive and negative areas of
contralateral and ipsilateral hemisphere, on sections with
320 mm interval, throughout the brain. The infarct volume was
assessed as the MAP-2 negative area in the ipsilateral hemisphere
and the ipsilateral hemisphere volume was assessed as the MAP-2
negative area plus the ipsilateral MAP-2 positive area.
Cell Counting and Astrocyte Histomorphology
Images of brain sections double stained with fluorescent
antibodies were captured through 3-dimensional Z-series consec-
utive scans with fluorescent signals detected and processed by a
confocal scanning laser microscope (Leica TCS SP2, Leica
Microsystems). Three images, representing three horizontal brain
regions, were sampled at the level of the striatum, starting medially
from the subventricular zone (SVZ), through the dorsal striatum
and laterally to the cortex. ImageJ (Image Processing and Analysis
in Java) 1.40 software was used to analyse the Z-series stacks.
Fluorescent positive cells were counted on 8 mm thick stacks of
confocal images within the 450 mm6300 mm optical fields in the
respective brain regions. The length of the longest cellular
processes of cortical astrocytes around the infarct area was
measured using a Leica DM 6000B microscope with a 406
objective and Stereoinvestigator 9 (MicroBrightField System, Inc)
on 8 mm thick S100 immunostained sections, as previously
described [11].
Quantitative real-time PCR
Wild-type mice were killed at 0 hours, 6 hours, 24 hours, 3
days, 7 days and 21 days after hypoxia-ischemia. The hippocam-
pus, striatum and cortex were dissected out and were quickly
frozen on dry-ice and store at -80uC. Total RNA was extracted
using RNeasy Lipid Tissue Mini Kit, including DNase treatment
(Qiagen). RNA concentrations were measured with a NanoDrop
ND-1000 spectrophotometer (Nanodrop Technologies) and RNA
integrity was checked on some randomly picked samples using the
Agilent 2100 bioanalyzer (Agilent Technologies). Reverse tran-
scription was performed with SuperScript III (Invitrogen)
according to the instructions of the manufacturer using a mixture
of 2.5 mM oligo (dT) and 2.5 mM random hexamers (both
Invitrogen) as primers. Temperature profile for reverse transcrip-
tion was 25uC for 5 minutes, 50uC for 60 minutes, 55uC for 15
minutes, and 70uC for 15 minutes. Real-time PCR measurements
were performed using a LightCycler 480 (Roche Diagnostics).
Temperature profile of real-time PCR was 95uC for 3 minutes,
followed by 50 cycles at 95uC for 20 seconds, 60uC for 20 seconds,
and 72uC for 20 seconds. Ten-microliter reactions contained iQ
SYBR Green Supermix (Bio-Rad) and 400 nM of each primer
(Eurofins MWG Operon). The following primer sequences were
used: Gfap_fwd: AACCGCATCACCATTCCT and Gfap_rev:
CGCATCTCCACAGTCTTTACC. Reference genes were eval-
uated using the Mouse Endogenous Control Gene Panel (TATAA
Biocenter) and NormFinder [30]. All data were geometrically
averaged against Pgk1 and B2m. Formation of correctly sized PCR
products was confirmed by agarose gel electrophoresis (2%) for all
assays and melting curve analysis for all samples. Data analysis was
performed as previously described [31,32].
Statistics
The Student t-test and Mann Whitney test was used for
statistical analysis between different time points or between the
animal groups (GraphPad Prism). The Wilcoxon signed rank test
was used to compare data between brain hemispheres from the
same animal. Results are given as mean 6 standard deviation
(SD). Statistical differences were considered significant if p,0.05.
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